Clinical trial
Experimental Study of Quality of Life in Patients With Endometriosis and Pelvic Pain Treated With Doliral Dietary Supplementation Versus Placebo.
NCT07393958 is registered in ClinicalTrials.gov with Arafarma Group, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Experimental Study of Quality of Life in Patients With Endometriosis and Pelvic Pain Treated With Doliral Dietary Supplementation Versus Placebo.
- Lead sponsor
- Arafarma Group, S.A.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 26, 2026
- Completion date
- September 15, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometriosis (diagnosis)